Results 141 to 150 of about 13,707,731 (353)
Stemness properties, including quiescence, self‐renewal, and chemoresistance, are closely associated with leukemia relapse. Here, we demonstrate that DNA damage‐inducible transcript 4 (DDIT4) is induced in the hypoxic bone marrow niche and is essential for maintaining the stemness of AML1‐ETO9a leukemia cells.
Yishuang Li+12 more
wiley +1 more source
Patch testing with the European baseline series and 10 added allergens: Single-centre study of 748 patients. [PDF]
Bizjak M+9 more
europepmc +1 more source
Limited Concordance Between “Oakmoss” and Colophony in Clinical Patch Testing [PDF]
Wolfgang Uter+4 more
openalex +1 more source
Proteomic and phosphoproteomic analyses were performed on lung adenocarcinoma (LUAD) tumors with EGFR, KRAS, or EML4–ALK alterations and wild‐type cases. Distinct protein expression and phosphorylation patterns were identified, especially in EGFR‐mutated tumors. Key altered pathways included vesicle transport and RNA splicing.
Fanni Bugyi+12 more
wiley +1 more source
The additive value of patch testing non-commercial test substances and patients' own products in a clinic of occupational dermatology. [PDF]
Aalto-Korte K, Pesonen M.
europepmc +1 more source
Exacerbation of allergic contact dermatitis from amcinonide triggered by patch testing [PDF]
Denis Sasseville
openalex +1 more source
Screening 166 FDA‐approved anticancer drugs identifies the aromatase inhibitor Exemestane as a synergistic partner of PARP inhibitor Olaparib in BRCA‐proficient triple‐negative breast cancer. Exemestane induces ROS‐mediated replication stress, enhancing DNA damage and apoptosis alongside Olaparib.
Nur Aininie Yusoh+5 more
wiley +1 more source
Patch testing results in adult patients with dermatitis during the coronavirus disease 2019 pandemic. [PDF]
Kong S, Mawhirt SL.
europepmc +1 more source